“Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.” A.U. Wells, J. Behr, U. Costabel, V. Cottin and V. Poletti. Eur Respir J 2012; 39: 805–806.
Related content which might interest you:
“Mast cells promote lung vascular remodelling in pulmonary hypertension.” J. Hoffmann, J. Yin, M. Kukucka, N. Yin, I. Saarikko, A. Sterner-Kock, H. Fujii, H. Leong-Poi, H. Kuppe, R.T. Schermuly and W.M. Kuebler. Eur Respir J 2011; 37: 1400–1410. Source: Eur Respir J 2012; 40: 515-517 Year: 2012
“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784. Source: Eur Respir J 2016; 48: 593 Year: 2016
"No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559". C. Dehnert, A.M. Luks, G. Schendler, E. Menold, M.M. Berger, H. Mairbäurl, V. Faoro, D.M. Bailey, C. Castell, G. Hahn, P. Vock, E.R. Swenson and P. Bärtsch. Eur Respir J 2010; 35: 812-820. Source: Eur Respir J 2010; 36: 699 Year: 2010
“Reproducibility of 6-minute walking test in patients with COPD”. N.A. Hernandes, E.F.M. Wouters, K. Meijer, J. Annegarn, F. Pitta and M.A. Spruit. Eur Respir J 2011; 38: 261–267. Source: Eur Respir J 2012; 40: 1583 Year: 2012
“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647. Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019 Year: 2020
Author Correction: “Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-?B and EGFR pathways.” C.A. Hewson, J.J. Haas, N.W. Bartlett, S.D. Message, V. Laza-Stanca, T. Kebadze, G. Caramori, J. Zhu, M.R. Edbrooke, L.A. Stanciu, O.M. Kon, A. Papi, P.K. Jeffery, M.R. Edwards and S.L. Johnston. Eur Respir J 2010; 36: 1425–1435. Source: Eur Respir J 2012; 39: 793 Year: 2012
“The therapy of idiopathic pulmonary fibrosis: what is next?” Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, et al . Eur Respir Rev 2019; 28: 190021. Source: Eur Respir Rev, 28 (153) 195021; 10.1183/16000617.5021-2019 Year: 2019
“Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.” Irene Lang, Bernhard C. Meyer, Takeshi Ogo, Hiromi Matsubara, Marcin Kurzyna, Hossein-Ardeschir Ghofrani, Eckhard Mayer and Philippe Brenot. Eur Respir Rev 2017; 26: 160119. Source: Eur Respir Rev, 26 (144) 165119; 10.1183/16000617.5119-2016 Year: 2017
“Contact investigation for tuberculosis: a systematic review and meta-analysis.” Gregory J. Fox, Simone E. Barry, Warwick J. Britton and Guy B. Marks. Eur Respir J 2013; 41: 140–156. Source: Eur Respir J 2015; 46: 578 Year: 2015
“Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.” M. Wilschanski, L.L. Miller, D. Shoseyov, H. Blau, J. Rivlin, M. Aviram, M. Cohen, S. Armoni, Y. Yaakov, T. Pugatch, M. Cohen-Cymberknoh, N.L. Miller, A. Reha, V.J. Northcutt, S. Hirawat, K. Donnelly, G.L. Elfring, T. Ajayi and E. Kerem. Eur Respir J 2011; 38: 59–69. Source: Eur Respir J 2011; 38: 996 Year: 2011
“Global strategy for asthma management and prevention: GINA executive summary.” E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143–178. Source: Eur Respir J, 51 (2) 0751387; 10.1183/13993003.51387-2007 Year: 2018
“Guidelines for the management of work-related asthma.” X. Baur, T. Sigsgaard, T.B. Aasen, P.S. Burge, D. Heederik, P. Henneberger, P. Maestrelli, J. Rooyackers, V. Schlünssen, O. Vandenplas and D. Wilken on behalf of the ERS Task Force on the Management of Work-related Asthma. Eur Respir J 2012; 39: 529–545. Source: Eur Respir J 2012; 39: 1553 Year: 2012
“Cellular mechanisms underlying steroid-resistant asthma.” Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021. Source: Eur Respir Rev, 28 (154) 195096; 10.1183/16000617.5096-2019 Year: 2019
“Health consequences associated with frequent wheezing in adolescents without asthma diagnosis.” K. Yeatts, K. Johnston Davis, D. Peden and C. Shy. Eur Respir J 2003; 22: 781–786. Source: Eur Respir J 2015; 46: 1532 Year: 2015
“Effect of different asthma treatments on risk of cold-related exacerbations.” H.K. Reddel, C. Jenkins, S. Quirce, M.R. Sears, E.D. Bateman, P.M. O'Byrne, M. Humbert, R. Buhl, T. Harrison, G.G. Brusselle, A. Thorén, U. Sjöbring, S. Peterson, O. Östlund and G.S. Eriksson. Eur Respir J 2011; 38: 584–593. Source: Eur Respir J 2012; 39: 1280 Year: 2012
Author Correction: “Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.” M. Sester, G. Sotgiu, C. Lange, C. Giehl, E. Girardi, G.B. Migliori, A. Bossink, K. Dheda, R. Diel, J. Dominguez, M. Lipman, J. Nemeth, P. Ravn, S. Winkler, E. Huitric, A. Sandgren and D. Manissero. Eur Respir J 2011; 37: 100–111. Source: Eur Respir J 2012; 39: 793 Year: 2012
“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230. Source: Eur Respir J, 52 (4) 1850230; 10.1183/13993003.50230-2018 Year: 2018
“Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma.” M. Ramael, J. Nagels, H. Heylen, S. De Schepper, J. Paulussen, M. De Maeyer and C. Van Haesendonck. Eur Respir J 1999; 14: 1381–1386. Source: Eur Respir J, 55 (5) 9951381; 10.1183/13993003.51381-1999 Year: 2020
“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057. Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018 Year: 2018
“Exhaled nitric oxide and the risk of wheezing in infancy: the Generation R Study.” C. Gabriele, V.W. Jaddoe, E. van Mastrigt, L.R. Arends, A. Hofman, H.A. Moll and J.C. de Jongste. Eur Respir J 2012; 39: 567–572. Source: Eur Respir J 2012; 39: 1281 Year: 2012